International Conference on Oncology (ICO) - Las Vegas, USA

  24 Nov 2025 - 25 Nov 2025

   Las Vegas, USA

conference-img

International Conference on Oncology (ICO) - Las Vegas, USA

24 Nov 2025

 - 

25 Nov 2025

Las Vegas, USA



Premier global event bringing together oncologists, oncosurgeons, researchers, and clinicians to discuss breakthroughs in oncological issues and oncological healthcare.

The event showcases cutting-edge oncology research, novel therapies, interactive sessions, keynote talks, and networking with global leaders advancing the diagnosis, treatment, and care of oncological diseases.

International Conference on Tumor Immunology and Immunotherapy (ICTII)- Las Vegas

On: 24 Nov 2025

-

25 Nov 2025


International Conference on Radiation Oncology (ICORAO-25)

On: 26 Nov 2025

-

27 Nov 2025


International Conference on Clinical Gynecology and Women Oncology (ICCGWO-25)

On: 28 Nov 2025

-

29 Nov 2025


5th International Conference on Cardiology

On: 28 Nov 2025

-

29 Nov 2025


International Conference on Surgical Oncology Nursing (ICSON-25)

On: 03 Dec 2025

-

04 Dec 2025


International Conference on Tumor Immunology and Immunotherapy (ICTII)- Las Vegas

On: 24 Nov 2025

-

25 Nov 2025


International Conference on Radiation Oncology (ICORAO-25)

On: 26 Nov 2025

-

27 Nov 2025


International Conference on Clinical Gynecology and Women Oncology (ICCGWO-25)

On: 28 Nov 2025

-

29 Nov 2025


5th International Conference on Cardiology

On: 28 Nov 2025

-

29 Nov 2025


International Conference on Surgical Oncology Nursing (ICSON-25)

On: 03 Dec 2025

-

04 Dec 2025



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

2.

An Intimate Life of Medical Innovation and Charity.

3.

Decoding calcifications in breast cancer: Towards personalized medicine

4.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

5.

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot